http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5256553-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ef4a0740cc751d5ff2fafd774a49b37
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
filingDate 1991-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6663401b757981e641f18104bf27acd8
publicationDate 1993-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5256553-A
titleOfInvention Multiple promoter transforming retroviral vectors
abstract A new class of oncogenic retroviral vectors is disclosed which comprise at least two oncogenes and a heterologous DNA sequence, each of which is independently transcribed in an infected or transfected cell under the control of a separate transcriptional control sequence.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5723333-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6113905-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003202967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6077510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6635624-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6995008-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019183124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6894157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006025362-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825097-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6429201-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732423-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8728763-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6133244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6015660-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6110743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003083291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6153429-A
priorityDate 1987-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4957865-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0235113-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0178996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8903872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0307248-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20054942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20054941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35766

Total number of triples: 57.